About Commonwealth Biotechnologies, Inc.
CBI offers cutting-edge research and development products and services to the global life sciences industry. CBI now operates through: (1) CBI Services, a discovery phase contract research organization; (2) Fairfax Identity Laboratories, a DNA reference business; (3) Mimotopes Pty Ltd, Melbourne, Australia, a peptide and discovery chemistry business; and (4) Venturepharm (Asia), Shanghai and Beijing, China, a contract research joint venture specializing in drug discovery and development, process scale-up, formulation development, cGMP manufacturing and clinical trial management. For more information, visit CBI on the web at www.cbi-biotech.com
Contacts: ZyGEM Commonwealth Biotechnologies Corporate: Media: Corporate/Media: Paul Kinnon Barbara Lindheim Thomas Reynolds President and CEO BioCom Partners EVP Science & Technology 858 720-8333 212 918-4650 804 648-3820
|SOURCE ZyGEM Corp. Ltd.|
Copyright©2009 PR Newswire.
All rights reserved